Company intelligence / Profile preview

CW Egg

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

CW Egg is a biotechnology company focused on developing innovative solutions for reproductive health and fertility. The company specializes in oocyte rejuvenation and advanced cell therapies designed to improve egg quality and success rates in assisted reproductive technologies. By leveraging proprietary platforms, CW Egg aims to address age-related fertility decline and hormonal imbalances. Their research integrates molecular biology and regenerative medicine to provide personalized treatment options for patients facing reproductive challenges.

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Cell therapySmall molecule
Industry: Biotech

Beyond the preview

Go deeper on CW Egg.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CW Egg.

Explore the full profile